Collectively, our findings provide compelling evidence that emodin effectively attenuates NLRP3-driven inflammation, establishing it as a promising candidate for the prevention of inflammatory and infectious diseases associated with aberrant NLRP3 inflammasome activation. The gene discussed is NLRP3; the disease is infectious disease.